Sagility Ltd

Sagility Share Pledge

Sagility B.V. disclosed release of indirect encumbrance on 56 crore shares after an on-market bulk deal sale. Promoter holding reduced from 50.95% to 38.99%.

Sagility Promoter Selling

Sagility B.V., a promoter, sold 560 million shares in the open market on November 2, 2026. Its stake fell from 50.95% to 38.99%.

Sagility Dividend

Sagility Limited declared an interim dividend of ₹0.15 per equity share for the financial year 2026-27. The record date is set for October 30, 2026.

Sagility Results Update

Sagility Ltd reported Q2 FY27 revenue of ₹2,032.1 Crore, up 22.5% YoY. The company also declared an interim dividend of ₹0.15 per share.

Sagility Investor Presentation: Key Takeaways

Sagility reported strong Q2 FY27 performance with 22.5% YoY revenue growth and 26.3% adjusted EBITDA margin. Performance driven by organic expansion in payer segments and strategic acquisition of Chirok Health.

Sagility Q2 FY27 Results: Net Profit ₹284.2 Cr, Up 13.3% YoY

Sagility Ltd reported revenue from operations of ₹2,032 Cr (+22.5% YoY) and net profit of ₹284.2 Cr (+13.3% YoY) for Q2 FY27.

Key figure

Net profit ₹284.2 Cr · +13.3% YoY

Sagility Acquisition Worth ₹304.1 Cr

Sagility's US subsidiary is acquiring Chirok Health LLC for up to US$ 32.35 million. This 100% stake acquisition strengthens Sagility's provider segment capabilities.

Value

₹304.1 Cr

Sagility Board Meeting Date

Sagility Ltd disclosed its Board is scheduled for 22 Oct 2026 to consider Q1/H1 FY27 results and any interim dividend. No decision has been taken yet.

Sagility Other Announcement

Sagility Ltd filed its quarterly shareholding pattern for the period ended September 30, 2026, disclosing promoter holdings and ongoing indirect encumbrances.

Sagility Management Change

Sagility Ltd announced the resignation of Daniel B. Bailey as Global General Counsel and the appointment of Brian Clayton to the same role, effective October 2, 2026.

Sagility Other Announcement

Sagility Limited informs shareholders that dividend payments have been processed. Shareholders with rejected payments must update KYC details with their DPs to receive withheld funds.

Sagility Management Change

Sagility Limited reported the re-appointment of Mr. Hari Gopalakrishnan as a Non-Executive Non-Independent Director following his retirement by rotation at the 5th Annual General Meeting.

Sagility Annual General Meeting

Sagility Limited conducted its 5th Annual General Meeting on August 20, 2026. Shareholders transacted ordinary business, including the adoption of financial statements and approval of final dividends.

Sagility Earnings Call Transcript: Key Takeaways

Sagility reported Q1 FY27 revenue of INR 19,635M, up 27.6% YoY. Strategy focuses on AI-led orchestration via the Synchrony platform and clinical service expansion through the CareSeed acquisition.

Call

Guides 10% growth

Sagility Annual General Meeting

Sagility Ltd has issued the notice for its 5th Annual General Meeting scheduled for August 20, 2026. The company provided the annual report for FY 2025-26.

Sagility Other Announcement

Sagility Limited has approved the re-appointment of PricewaterhouseCoopers Services LLP as Internal Auditor for an 18-month term starting October 1, 2026.

Execution

18 months

Sagility Business Update

Sagility Limited has re-appointed PricewaterhouseCoopers Services LLP as its internal auditor for the period from October 1, 2026, to March 31, 2028.

Sagility Results Update

Sagility reported Q1 FY27 revenue of ₹1,963.5 Crore, up 27.6% YoY. Adjusted PAT grew 35.1% to ₹269.7 Crore, driven by strong operational performance.

Sagility Board Meeting Outcome

Sagility Limited announced its board approved unaudited financial results for the quarter ended June 30, 2026. The meeting concluded on July 21, 2026.

Sagility Investor Presentation: Key Takeaways

Sagility reported strong Q1 FY27 results with 27.6% YoY revenue growth. Strategic focus remains on healthcare Payer operations, augmented by the acquisition of CareSeed for quality operations.

Sagility Q1 FY27 Results: Net Profit ₹216.8 Cr, Up 45.9% YoY

Sagility Ltd reported revenue from operations of ₹1,964 Cr (+27.6% YoY) and net profit of ₹216.8 Cr (+45.9% YoY) for Q1 FY27.

Key figure

Net profit ₹216.8 Cr · +45.9% YoY

Sagility Employee Stock Options

Sagility Limited submitted its registered ESOP Trust Deed for the 'ESOS 2026' scheme. The trust will administer employee stock options and performance stock units.

Sagility Board Meeting Date

Sagility Limited scheduled a board meeting on July 21, 2026. The board will consider and approve unaudited financial results for the quarter ended June 30, 2026.

Sagility Management Change

Sagility Limited recommended the re-appointment of Mr. Hari Gopalakrishnan as Non-Executive Non-Independent Director. The proposal is subject to shareholder approval at the upcoming AGM.

Sagility Annual General Meeting

Sagility Limited scheduled its AGM for August 20, 2026. The company fixed August 07, 2026, as the record date for determining final dividend entitlements.

Sagility Employee Stock Options

Sagility Ltd filed its ESOP Trust Deed to set up an employee stock option scheme. The trust’s initial corpus is Rs.10,000 (0.001 Crore).

Sagility Debt & Borrowing: ₹149.5 Cr

Sagility Ltd partially redeemed ₹149.5 Crore in NCDs. Interest for April-July 2026 was also paid to the debenture holder.

Value

₹149.5 Cr

Sagility Annual General Meeting

Sagility Ltd announced the voting results of a Postal Ballot. All resolutions, including the Employee Stock Options Scheme, were duly passed.

Sagility Acquisition Worth ₹304 Cr

Sagility Limited acquired 100% of US-based Careseed LLC for ₹304 Crore. The deal strengthens healthcare analytics and quality measurement capabilities within the U.S. payer ecosystem.

Value

₹304.0 Cr

Execution

11-06-2026

Sagility Acquisition

Sagility acquired CareSeed, a U.S. healthcare analytics firm, for an undisclosed sum. The deal strengthens its Medicare Advantage and AI-led quality operations capabilities.